ECG-I Targeted Ablation for Persistent AF Not Responding to Pulmonary Vein Isolation Results of a Two Staged Strategy.

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 150 participants.

Also called NCT04633265

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 150 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04633265
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04633265. Allocation not applicable; no masking; primary purpose treatment. Start 2018-01-10 (actual); primary completion 2021-03-31 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
ECG-I Targeted Ablation for Persistent AF Not Responding to Pulmonary Vein Isolation Results of a Two Staged Strategy.
Acronym
TARGET-AF2
Intervention (Device)
ECG-I Mapping of Atrial Fibrillation
Lead sponsor
Barts & The London NHS Trust (class: other)

Record details

Record id
cardio:ct-nct04633265
Content hash
53bc8d5b4816d60533f2fef55c7505d89d07dbdf6da326af4702c756a18c81fe